The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 359:1181-1182 September 11, 2008 Number 11
NextNext

Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Ray, W. A.
-Related Article
by Fergusson, D. A.
-PubMed Citation
To the Editor: Fergusson et al. (May 29 issue)1 report the findings of the Blood Conservation Using Antifibrinolytics in a Randomized Trial (BART) study. They found a negative mortality trend associated with aprotinin as compared with lysine analogues among patients undergoing high-risk cardiac surgery. This trend could be explained by an increased risk of death from a cardiac cause. In contrast to the study by Mangano et al.,2 the BART study revealed no increase in the risk of stroke or renal failure among patients receiving aprotinin.

In an editorial accompanying the article by Fergusson et al., Ray and Stein3 raise . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.